GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SANUWAVE Health Inc (OTCPK:SNWV) » Definitions » Beneish M-Score
中文

SANUWAVE Health (SANUWAVE Health) Beneish M-Score

: -4.96 (As of Today)
View and export this data going back to 2008. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.96 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for SANUWAVE Health's Beneish M-Score or its related term are showing as below:

SNWV' s Beneish M-Score Range Over the Past 10 Years
Min: -33.49   Med: -5.39   Max: 23.99
Current: -4.96

During the past 13 years, the highest Beneish M-Score of SANUWAVE Health was 23.99. The lowest was -33.49. And the median was -5.39.


SANUWAVE Health Beneish M-Score Historical Data

The historical data trend for SANUWAVE Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SANUWAVE Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.69 23.99 -5.82 -4.24 -4.96

SANUWAVE Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.24 -4.66 -4.19 -5.22 -4.96

Competitive Comparison

For the Medical Devices subindustry, SANUWAVE Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SANUWAVE Health Beneish M-Score Distribution

For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where SANUWAVE Health's Beneish M-Score falls into.



SANUWAVE Health Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of SANUWAVE Health for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.6752+0.528 * 1.0527+0.404 * 0.8363+0.892 * 1.2182+0.115 * 1.007
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.5562+4.679 * -0.518737-0.327 * 0.9537
=-4.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $3.31 Mil.
Revenue was 6.994 + 4.953 + 4.675 + 3.775 = $20.40 Mil.
Gross Profit was 4.835 + 3.541 + 3.473 + 2.513 = $14.36 Mil.
Total Current Assets was $9.78 Mil.
Total Assets was $22.42 Mil.
Property, Plant and Equipment(Net PPE) was $0.94 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.03 Mil.
Selling, General, & Admin. Expense(SGA) was $13.57 Mil.
Total Current Liabilities was $64.76 Mil.
Long-Term Debt & Capital Lease Obligation was $0.49 Mil.
Net Income was 18.235 + -23.7 + -7.262 + -13.08 = $-25.81 Mil.
Non Operating Income was 20.319 + -19.324 + -3.812 + -6.824 = $-9.64 Mil.
Cash Flow from Operations was -1.285 + -2.038 + -0.844 + -0.371 = $-4.54 Mil.
Total Receivables was $4.03 Mil.
Revenue was 5.5 + 4.166 + 3.882 + 3.195 = $16.74 Mil.
Gross Profit was 4.31 + 3.009 + 2.786 + 2.306 = $12.41 Mil.
Total Current Assets was $6.62 Mil.
Total Assets was $19.87 Mil.
Property, Plant and Equipment(Net PPE) was $0.86 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.95 Mil.
Selling, General, & Admin. Expense(SGA) was $20.03 Mil.
Total Current Liabilities was $60.22 Mil.
Long-Term Debt & Capital Lease Obligation was $0.44 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(3.314 / 20.397) / (4.029 / 16.743)
=0.162475 / 0.240638
=0.6752

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(12.411 / 16.743) / (14.362 / 20.397)
=0.741265 / 0.704123
=1.0527

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (9.784 + 0.938) / 22.416) / (1 - (6.62 + 0.856) / 19.873)
=0.521681 / 0.623811
=0.8363

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=20.397 / 16.743
=1.2182

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.952 / (0.952 + 0.856)) / (1.028 / (1.028 + 0.938))
=0.526549 / 0.522889
=1.007

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(13.571 / 20.397) / (20.03 / 16.743)
=0.665343 / 1.196321
=0.5562

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.492 + 64.755) / 22.416) / ((0.438 + 60.215) / 19.873)
=2.910733 / 3.05203
=0.9537

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-25.807 - -9.641 - -4.538) / 22.416
=-0.518737

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

SANUWAVE Health has a M-score of -4.96 suggests that the company is unlikely to be a manipulator.


SANUWAVE Health Beneish M-Score Related Terms

Thank you for viewing the detailed overview of SANUWAVE Health's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


SANUWAVE Health (SANUWAVE Health) Business Description

Traded in Other Exchanges
N/A
Address
11495 Valley View Road, Eden Prairie, MN, USA, 30024
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
Executives
Andrew Walko officer: President 11495 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Manchester Management Pr, Llc director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02114
James E Besser director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02114
Manchester Explorer, L.p. director, other: Director by Deputization MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
Morgan C. Frank director 2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc director, other: Director by Deputization 3 WEST HILL PLACE, BOSTON MA 02110
Thomas Edmunds Price director 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Shri P. Parikh officer: President 3360 MARTIN FARM ROAD, SUITE 100, SUWANEE GA 30024
Richardson Kevin A Ii 10 percent owner 200 HIGH STREET, SUITE 700, BOSTON MA 02110
Anthony Michael Stolarski director 99 W. ARLINGTON HEIGHTS, NORTH AUGUSTA SC 29841
Sanuwave Health, Inc. director 3360 MARTIN FARM RD, SUITE 100, SUWANEE GA 30024
Lisa E Sundstrom officer: Interim CFO 11475 GREAT OAKS WAY, STE 150, ALPHARETTA GA 30022
Joseph Chiarelli director, officer: Chief Executive Officer 510 FAIRVIEW AVENUE, WYCKOFF NJ 07481
Barry J. Jenkins officer: Chief Financial Officer 11680 GREAT OAKS WAY, SUITE 350, ALPHARETTA GA 30022
Alan L Rubino director PO BOX 376, LOBBY L., ANN ARBOR MI 48105

SANUWAVE Health (SANUWAVE Health) Headlines

From GuruFocus

SANUWAVE Announces New Board Leadership

By GuruFocusNews GuruFocusNews 04-12-2022

SANUWAVE Health Provides Business Update

By Marketwired Marketwired 09-28-2021

SANUWAVE Business Update

By GuruFocusNews GuruFocusNews 06-17-2022

SANUWAVE Health to Host Conference Call and Provide Business Update

By GuruFocusNews GuruFocusNews 01-18-2022

SANUWAVE Health to Host Conference Call and Provide Business Update

By GuruFocusNews GuruFocusNews 02-28-2022

SANUWAVE Business Update

By GuruFocusNews GuruFocusNews 06-07-2022

SANUWAVE Health Provides Updated Conference Call Information

By ACCESSWIRE ACCESSWIRE 07-14-2021

SANUWAVE Health to Present at Q2 Virtual Investor Summit

By ACCESSWIRE ACCESSWIRE 05-12-2021

SANUWAVE� Business Update

By GuruFocusNews GuruFocusNews 04-08-2022